Tracy Williams, CEO of Olmstead Williams Communications, will participate in a panel discussion titled “Using the Media: How to Out-Market Your Competition and Increase Your PR Visibility” at the CTA Expo Emerging Managers Forum on December 8, 2016 at the Nobu Hotel in Eden Roc Miami. The forum provides emerging hedge funds and CTAs from the U.S., Europe and Latin America the opportunity to network and exchange ideas with capital sources. Williams will be joined by Matthias Knab, the founder of Opalesque LTD in a panel moderated by Mark DeSouza, the CIO of Cohesion Partners.
Oberthur Technologies, the leader in embedded security solutions, has developed a dynamic CVV (credit verification value) solution called MOTION CODE with a tiny screen that changes the three or four-digit CVV number on the back of credit and debit cards as often as 72 times every 24 hours. The Los Angeles Times sat down with Martin Ferenczi, OT’s president for North America, to discuss the payments market, the United States’ transition into chip card technology and the new MOTION CODE cards which make online purchases safer.
“There is a constant balancing act between security and simplicity,” Ferenczi said. “MOTION CODE solves this better than any other option.”
Read the full article: The future of credit card security may involve blinking numbers (LA Times)
Olmstead Williams Communications CEO and president Tracy Williams will address how businesses and other organizations can “Make the Media work for You” at 1 p.m. on Tuesday at Opal Group’s Marketplace Lending & Alternative Financing Summit. The event runs from December 4 through 6 at the Monarch Beach Resort in Dana Point, Calif., and is designed for investors, issuers, platforms, underwriters, banks rating agencies, lawyers, service providers, accountant and other related industry professionals.
Williams also will moderate a panel on student loans with thought leaders such as Joseph DePaulo, CEO & Co-Founder, College Ave Student Loans; Zander Rafael, CEO, Climb Credit; Jeff Silberman, SVP, Structured Finance and Institutional Business Development, LendKey; and Brian Norton, CEO, Future Finance Loan Corp.
Cynvenio Biosystems’ innovative LiquidBiopsy® technology is being used at USC and the Mayo Clinic to find mutating tumor cells in the blood and help doctors diagnose and treat cancer without the need for a surgical biopsy. The company began shipping the system earlier this year and ultimately wants to put one in every cancer clinic.
“This is the first complete system, from blood draw to DNA sequencing,” said Chief Executive André de Fusco. “If we find a number of cancer cells that are not heavily mutated, fine. But if they are mutated, those cells can be targeted by drugs from the big pharma companies.”
Read the full article:
Cutting Edge Without The Knife